His primary scientific interests are in Cystic fibrosis, Internal medicine, Respiratory disease, Surgery and Pathology. His Cystic fibrosis research incorporates elements of Pseudomonas aeruginosa, Antibiotics and Nitric oxide. His work deals with themes such as Gastroenterology, Endocrinology and Intensive care medicine, which intersect with Internal medicine.
His Gastroenterology research includes themes of Inhalation and Respiratory system. Felix Ratjen works mostly in the field of Respiratory disease, limiting it down to topics relating to Vital capacity and, in certain cases, Chemotherapy, Chemoprophylaxis and Respiratory tract. His study looks at the relationship between Surgery and topics such as Spirometry, which overlap with Crossover study, Lung, Obstructive lung disease and Washout.
Felix Ratjen spends much of his time researching Cystic fibrosis, Internal medicine, Pulmonary function testing, Lung Clearance Index and Gastroenterology. Felix Ratjen interconnects Immunology, Pathology, Pseudomonas aeruginosa, Intensive care medicine and Lung in the investigation of issues within Cystic fibrosis. His research integrates issues of Clinical trial and Lung disease in his study of Intensive care medicine.
The various areas that he examines in his Internal medicine study include Endocrinology, Antibiotics, Surgery and Cardiology. His Surgery research is multidisciplinary, incorporating elements of Anesthesia and Inhalation. As a member of one scientific family, Felix Ratjen mostly works in the field of Lung Clearance Index, focusing on Pediatrics and, on occasion, Asthma.
The scientist’s investigation covers issues in Cystic fibrosis, Internal medicine, Lung Clearance Index, Spirometry and Pulmonary function testing. Felix Ratjen works in the field of Cystic fibrosis, namely Ivacaftor. His Internal medicine study combines topics in areas such as Gastroenterology, Mutation and Cardiology.
His Lung Clearance Index study incorporates themes from Nitrogen washout, Breathing, Nuclear medicine and MULTIPLE BREATH WASHOUT. His biological study spans a wide range of topics, including Physical therapy and Washout. His Intensive care medicine research integrates issues from Pharmacotherapy and MEDLINE.
His primary areas of study are Cystic fibrosis, Internal medicine, Lung Clearance Index, Breathing and Spirometry. He has included themes like Intention-to-treat analysis, Lung and Intensive care medicine in his Cystic fibrosis study. Felix Ratjen has researched Internal medicine in several fields, including Pseudomonas aeruginosa, Tobramycin and Cardiology.
His work is dedicated to discovering how Lung Clearance Index, MULTIPLE BREATH WASHOUT are connected with Inhalation, Washout, Pediatrics, Reference values and Functional residual capacity and other disciplines. His work carried out in the field of Breathing brings together such families of science as Magnetic resonance imaging, Pulmonary function testing and Lung disease. His study in Spirometry is interdisciplinary in nature, drawing from both Data quality, Concordance, Methacholine and Bronchial hyperresponsiveness.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation
Bonnie W. Ramsey;Jane Davies;N. Gerard McElvaney;Elizabeth Tullis.
The New England Journal of Medicine (2011)
Consensus statement for inert gas washout measurement using multiple- and single- breath tests
Paul D. Robinson;Philipp Latzin;Sylvia Verbanck;Graham L. Hall.
European Respiratory Journal (2013)
European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
Alan R. Smyth;Scott C. Bell;Snezana Bojcin;Mandy Bryon.
Journal of Cystic Fibrosis (2014)
Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society.
J de Blic;F Midulla;A Barbato;A Clement.
European Respiratory Journal (2000)
Exhaled nitric oxide in pulmonary diseases: a comprehensive review.
Peter J. Barnes;Raed A. Dweik;Arthur F. Gelb;Peter G. Gibson.
ECFS best practice guidelines: the 2018 revision
Carlo Castellani;Alistair J.A. Duff;Alistair J.A. Duff;Scott C. Bell;Harry G.M. Heijerman.
Journal of Cystic Fibrosis (2018)
Measurement of exhaled nitric oxide in children, 2001
E. Baraldi;J. C. de Jongste;B. Gaston;K. Alving.
European Respiratory Journal (2002)
Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein.
Amy P Wong;Christine E Bear;Stephanie Chin;Peter Pasceri.
Nature Biotechnology (2012)
The Effect of Chronic Infection With Aspergillus fumigatus on Lung Function and Hospitalization in Patients With Cystic Fibrosis
Reshma Amin;Annie Dupuis;Shawn D. Aaron;Felix Ratjen.
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
Lisa Saiman;Michael Anstead;Nicole Mayer-Hamblett;Larry C. Lands.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: